US
(888) 440-0954

The global diabetes community united again at the IDF 2017 Congress in Abu Dhabi, UAE, from 4 to 8 December 2017 under the Patronage of His Highness Sheikh Mohammed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and with high level participation from the Abu Dhabi Department of Health.

IDF 2017 Congress

04December2018 - 08December2018

Abu Dhabi, UAE


https://www.idf.org/our-activities/congress.html

AAO 2018, in conjunction with the Pan-American Association of Ophthalmology (PAAO), will take place in McCormick Place, Chicago.

Why Chicago? Like ophthalmology, it perfectly combines Art + Science. From world-renowned art and science museums, to cutting-edge theater, to blues clubs, to inventive chefs, to breathtaking architecture and engineering – no other city offers more to see, hear and experience.

AAO 2018 Annual Meeting

27October2018 - 30October2018

McCormick Place, Chicago


https://www.aao.org/annual-meeting/chicago

The American Society of Human Genetics Annual Meeting is held each fall in a major U.S. or Canadian city and attracts over 7,000 scientific attendees, plus almost 250 exhibiting companies, which makes it the world’s largest gathering of human genetics professionals.

ASHG Annual Meeting

16October2018 - 20October2018

San Diego, USA


http://www.ashg.org/2018meeting/

CHI’s 6th Annual Immuno-Oncology Summit 2018

27August2018 - 31August2018

Seaport World Trade Center, Boston, MA


http://www.immuno-oncologysummit.com

During this webcast the speaker will address:

  • Challenges in accurate prediction of immunogenic neoantigens
  • Benefits of the OncoPeptVAC platform
  • Assay for immunogenicity of peptides predicted using OncoPeptVAC using OncoPeptSCRN
  • Insights into the discoveries made possible using OncoPeptVAC in combination with OncoPeptSCRN & TCR repertoire assays
  • Benefits of TCR repertoire profiling to assay for immunogenicity

25July2018

Foster City, CA 94404, USA


http://www.workcast.com/register?cpak=2954322885648975

Considering genomic research?

We’re at your service

*
 
*
*